GlassScriptPhysician profile
Frank C Lai
NPI 1023067329
$15,561.18
in general payments reported to CMS, 2019-2025
56 companies · $3,021 in 2025
The $3,021 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,995 · 2020: $917 · 2021: $1,637 · 2022: $3,173 · 2023: $2,927 · 2024: $1,890 · 2025: $3,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,301 · Travel and Lodging: $534 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,300.52 |
| Travel and Lodging | $533.53 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,918.40 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $1,677.40 | 2021-2022 | |
| Angiodynamics, INC. | $1,200.22 | 2022-2025 | Nanoknife |
| Astellas Pharma US INC | $1,169.58 | 2019-2025 | Myrbetriq, Xtandi, Padcev |
| Edap Technomed INC | $1,001.02 | 2023-2024 | |
| Dendreon Pharmaceuticals LLC | $869.18 | 2019-2025 | Provenge |
| Abbvie INC. | $631.56 | 2019-2025 | |
| Urovant Sciences INC | $601.64 | 2021-2022 | |
| Neotract INC. | $527.30 | 2019-2020 | |
| Pfizer INC. | $472.04 | 2019-2025 | |
| Janssen Biotech, INC. | $465.55 | 2019-2024 | Erleada, Akeega, Balversa |
| Boston Scientific Corporation | $463.72 | 2019-2023 | Lithovue |
| Antares Pharma, INC. | $431.36 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $390.16 | 2019-2025 | Adstiladrin |
| Coloplast Corp | $387.91 | 2020-2025 | Titan |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.